Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -5.087% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) COc1cc2c(cc1OC)C(c1ccc3c(c1)OCO3)C1=C(CC(C)(C)CC1=O)N2
b) CCc1nn(CC(=O)NCCCN2CCOCC2)c(=O)c2cc3cc(F)ccc3n12
c) CCOC(=O)c1c(/N=C/C2C(=O)NC(=S)NC2=O)sc2c1CCC2
Answer: b. CCc1nn(CC(=O)NCCCN2CCOCC2)c(=O)c2cc3cc(F)ccc3n12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nn(CC(=O)NCCCN2CCOCC2)c(=O)c2cc3cc(F)ccc3n12
CCc1nn(CC(=O)NCCCN2CCOCC2)c(=O)c2cc3cc(F)ccc3n12
2-(4-ethyl-8-fluoro-1-oxo-[1,2,4]triazino[4,5-a]indol-2-yl)-N-(3-morpholin-4-ylpropyl)acetamide